Ubs Asset Management Americas Inc Iovance Biotherapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,946,842 shares of IOVA stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,946,842

Previous 1,994,500 2.39%

Holding current value

$14 Million

Previous $16 Million 14.29%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.28 - $11.9 $346,950 - $567,130	-47,658 Reduced 2.39%	1,946,842 $18.3 Million
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $14.1 Million - $25.7 Million	1,814,650 Added 1008.98%	1,994,500 $16 Million
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $356 - $821	-47 Reduced 0.03%	179,850 $2.67 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $5,824 - $15,690	-1,765 Reduced 0.97%	179,897 $1.46 Million
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $237,500 - $470,185	53,491 Added 41.73%	181,662 $826,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $272,901 - $375,417	-28,636 Reduced 18.26%	128,171 $1.23 Million
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $387,444 - $1.11 Million	-60,728 Reduced 27.92%	156,807 $1.73 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $488,688 - $753,953	39,474 Added 22.17%	217,535 $3.62 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $63,452 - $105,933	3,834 Added 2.2%	178,061 $3.4 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $34,269 - $44,844	-1,684 Reduced 0.96%	174,227 $4.3 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $2.19 Million - $4.43 Million	-134,088 Reduced 43.25%	175,911 $4.58 Million
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $16,886 - $30,975	-589 Reduced 0.19%	309,999 $9.81 Million
Q4 2020 Mar 01, 2021	BUY	$28.04 - $50.26 $575,689 - $1.03 Million	20,531 Added 7.08%	310,588 $14.4 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $416 - $544	-15 Reduced 0.01%	290,057 $9.55 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $732,411 - $1.1 Million	26,917 Added 10.23%	290,072 $7.96 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $3.01 Million - $5.99 Million	154,293 Added 141.73%	263,155 $7.88 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $489,191 - $801,510	27,253 Added 33.39%	108,862 $3.01 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $346,379 - $500,604	19,254 Added 30.88%	81,609 $1.49 Million
Q2 2019 Aug 15, 2019	BUY	$9.78 - $24.52 $150,318 - $376,872	15,370 Added 32.71%	62,355 $0
Q4 2018 Feb 13, 2019	BUY	$7.51 - $11.93 $80,184 - $127,376	10,677 Added 29.41%	46,985 $415,000
Q1 2018 May 14, 2018	BUY	$8.1 - $19.5 $210,980 - $507,916	26,047 Added 253.84%	36,308 $0
Q3 2017 Nov 13, 2017	BUY	$4.45 - $8.55 $45,661 - $87,731	10,261	10,261 $0

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.13B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Iovance Biotherapeutics, Inc. Transaction History